COVID-19 Summit Sees Progress On Test-And-Treat, IP Licensing, & Funding Commitments

$712m More Pledged For World Bank Pandemic Preparedness Fund

Announcements at the second Global COVID-19 Summit included a technology licensing agreement for vaccine and diagnostic products developed by the US NIH, a new partnership to boost the use of testing and antiviral treatments in less wealthy countries, and a flurry of new funding pledges from organizations and companies alike.

Coronavirus all around the world, the spread of novel coronavirus, Covid-2019, dangerous virus, pandemic
Global efforts to tackle COVID-19 are escalating • Source: Shutterstock

A new consortium has been launched to promote the use of COVID-19 testing and antiviral treatment programs in lower-income countries (LMICs) to help shape the response to COVID-19 and other future pandemics.

Initially, the public-private consortium plans to support a “test-and-treat” demonstration program covering four countries to be identified over the coming...

More from Vaccines

More from Pink Sheet

What Pharma Needs To Know About Vietnam’s Drug Registration Reforms

 

Newly introduced rules for streamlining drug registration in Vietnam are said to present both opportunities and challenges for stakeholders.

European Industry Calls For Support As It Juggles Multiple Challenges

 
• By 

At Medicines for Europe’s legal and annual conferences in Brussels last week, multiple key issues competed for attention, giving the generics and biosimilars industry plenty to think about at a critical time for EU pharma reform.

England’s NHS Plan Eyes Cancer Vaccine Boost, Single Formulary & ‘Pay For Impact’ Drug Deal

 

The creation of a single national formulary for medicines prescribing that could impact industry is among the action points in the UK government’s new 10-year health plan for the National Health Service in England.